Semaglutide vs Tirzepatide: Which Weight Loss Medication Is Right for You?

Both Semaglutide (Wegovy/Ozempic) and Tirzepatide (Mounjaro/Zepbound) are advancing medications for weight loss, but they work differently.

Semaglutide: The Pioneer

Semaglutide is a GLP-1 receptor agonist that: - Was the first of its kind FDA-approved for weight loss - Helps regulate appetite and blood sugar - Shows average weight loss of 15-20% of body weight

Tirzepatide: The Dual-Action Approach

Tirzepatide is a dual GIP/GLP-1 receptor agonist that: - Activates two hormone pathways instead of one - May produce slightly higher weight loss results - Is newer to the market with ongoing research

Which Is Right for You?

The personalized choice depends on your individual health profile, weight loss goals, and how your body responds to treatment. Dr. Vaidya can help you determine the optimal medication for your needs.

Individual results vary. This information is for educational purposes only and does not constitute medical advice. Consult with Dr. Vaidya at (919) 322-2844 to determine if this approach is appropriate for your health goals.